LINK: IN PERSON

OBJECTIVES: Upon completion of this activity, the participant should be able to:   (1) Identify the appropriate NCCN and ASH guidelines, (2) Recognize common presenting symptoms and understand treatment modalities for patients with leukemia.  (3) Analyze clinical trials available for leukemic patients through the Baylor Research Institute.

PLANNER/MODERATOR DISCLOSURE:  Micah Burch, MD and Lake Littlejohn, MD , have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


For information, please contact Jennifer Olvera at Jennifer.Olvera@bswhealth.org

 

Session date: 
08/17/2022 - 12:30pm to 1:30pm CDT
Location: 
Baylor Charles A. Sammons Cancer Center - Dallas Campus
3410 Worth Street Ste 580
Dallas, TX 75246
United States
  • 1.00 AMA PRA Category 1 Credit
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance

Please login or register for this course.